Use of gonadotropins in ovarian stimulation in Spain: Delphi consensus

References

• Alviggi, C., et al., 2016. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertility and Sterility, 105 (6), 1452–1453.
   PubMed Web of Science ®Google Scholar
• Bosch, E., Broer, S. and Griesinger, G., 2020. The ESHRE Guideline Group On Ovarian Stimulation. ESHRE guideline: ovarian stimulation for IVF/ICSI. Human Reproduction Open, 2020 (2), hoaa009.
   Google Scholar
• Bulletti, C., et al., 2021. How fixed versus variable gonadotropin dose during controlled ovarian stimulation could influence the management of infertility patients undergoing IVF treatment: a national Delphi consensus. Gynecological endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 37 (3), 255–263.
   PubMed Web of Science ®Google Scholar
• Drakopoulos, P., Blockeel, C. and Stoop, D., 2016. Estimulação ovariana convencional e caracterization de embrião único para FIV/ICSI. Quantos oócitos precisamos para maximizar as taxas cumulativas de nascidos vivos após a utilização de todos os embriões frescos e congelados? Human Reproduction, 31, 370–376.
   PubMed Web of Science ®Google Scholar
• Ferrando, M., et al., 2020. The continuum of ovarian response leading to BIRTH, a real-world study of art in Spain. Fertility Research and Practice, 6, 13.
   PubMedGoogle Scholar
• Goldman, K. N., et al., 2013. Oocyte efficiency: does live birth rate differ when analyzing cryopreserved and fresh oocytes on a per-oocyte basis? Fertility and Sterility, 100 (3), 712–717.
   PubMed Web of Science ®Google Scholar
• Goldman, R. H., et al., 2017. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Human Reproduction, 32 (4), 853–859.
   PubMed Web of Science ®Google Scholar
• Howles, C. M., et al., 2006. Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients. Current Medical Research and Opinion, 22 (5), 907–918.
   PubMed Web of Science ®Google Scholar
• Humaidan, P., et al., 2017. Efficacy and safety of follitropin alfa/lutropin alfa in art: a randomized controlled trial in poor ovarian responders. Human Reproduction, 32 (3), 544–555.
   PubMed Web of Science ®Google Scholar
• Imthurn, B., et al., 2014. Evaluation of the use and handling of three different pen systems considered for in vitro fertilization treatment. Expert Opinion on Drug Delivery, 11 (12), 1859–1864.
   PubMed Web of Science ®Google Scholar
• La Marca, A., et al., 2016. The use of ovarian reserve markers in IVF clinical practice: a national consensus. Gynecological Endocrinology : The Official Journal of the International Society of Gynecological Endocrinology, 32 (1), 1–5.
   PubMed Web of Science ®Google Scholar
• Olgan, S. and Humaidan, P., 2017. GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study. Reproductive Biology, 17 (1), 105–110.
   PubMed Web of Science ®Google Scholar
• Orvieto, R., et al., 2021. Optimising follicular development, pituitary suppression, triggering and luteal phase support during assisted reproductive technology: a delphi consensus. Frontiers in Endocrinology, 12, 675670.
   PubMed Web of Science ®Google Scholar
• Pandian, Z., et al., 2010. Interventions for ‘poor responders’ to controlled ovarian hyper stimulation (COH) in in-vitro caracterization (IVF). Cochrane Database of Systematic Reviews, (1), CD004379.
   PubMed Web of Science ®Google Scholar
• Papathanasiou, A., et al., 2016. Trends in 'poor responder’ research: lessons learned from RCTs in assisted conception. Human Reproduction Update, 22 (3), 306–319.,
   PubMed Web of Science ®Google Scholar
• Quintero, L. A., Verdú, V. and De la Fuente, L., 2016. Evaluación del uso y manejo de la pluma Bemfola® en comparación con el de la pluma Gonal-f® y la pluma Puregon® en pacientes potenciales de FIV/donantes de ovocitos. Revista Iberoamericana de Fertilidad y Reproducción, 33 (3), 42–51.
   Google Scholar
• Roque, M., et al., 2021. The POSEIDON stratification – moving from poor ovarian response to low prognosis. JBRA Assisted Reproduction, 25 (2), 282–292.
   PubMed Web of Science ®Google Scholar
• Saunders, H., Bjaergestad, L., Donat, H., 2020. Suitability of multidose vs single dose gonadotropin injection pens for ART use: A usability pen study. Poster presented at the American Society for Reproductive Medicine (ASRM) Virtual Congress, October 2020. Available in: https://www.fertstert.org/article/S0015-0282(20)31313-3/fulltext#relatedArticles. Last access September 2022.
   Google Scholar
• Selman, H. and Rinaldi, L., 2016. Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patients. International Journal of Women’s Health, 8, 609–615.
   PubMed Web of Science ®Google Scholar
• Siristatidis, C., Sergentanis, T. N., and Kanavidis, P., 2013. Hiperestimulação ovariana controlada para fertilização in vitro: impacto no cáncer ovariano, endometrial e cervical – uma revisão sistemática e metaanálise. Atualização Human Reproduction, 19, 105–123.
   Google Scholar
• Sociedad Española de Fertilidad 2019. Registro Nacional de Actividad 2019-Registro SEF. [Last access September 2022]. Available in: https://www.registrosef.com/public/docs/sef2019_IAFIVm.pdf
   Google Scholar
• Strowitzki, T., et al., 2016. Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART). Reproductive Biology and Endocrinology, 14, 1.
   PubMed Web of Science ®Google Scholar
• Tarlatzis, B. C., et al., 2003. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Human Reproduction Update, 9 (1), 61–76.
   PubMed Web of Science ®Google Scholar
• Ulug, U., et al., 2003. Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reproductive Biomedicine Online, 6 (4), 439–443.
   PubMedGoogle Scholar
• Vlaisavljević, V., et al., 2010. An observational study of assisted reproductive technology outcomes in new European Union member states: an overview of protocols used for ovarian stimulation. Current Medical Research and Opinion, 26 (4), 819–825.
   PubMed Web of Science ®Google Scholar